Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Entertainment
  • Business
  • Real Estate
  • Technology
  • Health
  • Non-profit
ncarol.com

Labratfinder.com launches the COVID-19 web research info center as "Who is Who, Where is Who, and Who Uses What Products" free to access web page
ncarol.com/10054021

Trending...
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 123
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform - 120
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs - 115
Zoom-in view of the map widget on Labratfinder.com View of the map widget in Labratfinder.com VIew on the entire Labratfinder.com COVID19 widget Labratfinder LLC
Labratfinder.com is bringing the latest in COVID-19 research, in the form of the "Who is Who, Where is Who and Who Uses What Products" page. Based on the Artificial Intelligence analysis of millions of published peer-reviewed publications, Labratfinder.com presents the summarized reports of: researchers, research publications, products, brands used in COVID-19 research and geographical distribution of research institutions.

SILVERADO, Calif. - ncarol.com -- Labratfinder.com is a novel artificial intelligence based system for discovering the true end users of scientific products, key opinion leaders and prospecting collaborators. This free resource is aimed to help researches and other parties of interest across the globe involved in COVID-19 research to find the latest published information and identify potential collaborators, research products, and appropriate research techniques.

Their "Who Is Who, Where is Who and Who uses What in a World of COVID-19" resource page is based on the Artificial Intelligence analysis of millions of published peer-reviewed publications for a specific combination of keywords. On this page, one can see:

More on ncarol.com
  • Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
  • Lake Norman Philharmonic Annual Holiday Concert 2026
  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
  • Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail

  • Organizations and scientists involved on an interactive map;
  • Browse through the list or researchers with contact info and all relevant publications;
  • Find out which major brands of life science research products are used in COVID-19 research; and how they are used by reading the references;
  • And find how a particular research or laboratory / analytical techniques was used in the COVID-19 research.
The results are provided in an easy to search, exportable tables, ranked by: dates; number of publications; number of citations; and in a graphical interactive form representing the geographic distribution of information in a map based infographics.

This free, daily updated "Who is Who, Where is Who and Who Uses What in a World of COVID-19 Research page" can be readily accessed by clicking on this web page link: http://www.labratfinder.com/covid-19.

Media Contact
Prof. Miodrag "Mickey" Micic, Sc.D.,Ph.D.,, M.T.M.
President / CEO
mm@labratfinder.com
9499811068


Source: Labratfinder LLC

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
  • Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
  • The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
  • Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
  • HIRO Ostomy Belt Launch by Richard O'Hamill
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • Lake Norman Philharmonic - Free Holiday Concert
  • S&P 500's 4.4% Plunge: Buy the Dip or Wait? KayeDinero Spotlights TrendSetter
  • Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
  • The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
  • Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
  • ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
_catLbl0 _catLbl1

Popular on ncarol.com

  • Parade of Homes Winners Announced - 256
  • Nious Media Expands Independent Entertainment Network Through Gaming, Music and Digital Storytelling - 193
  • North Carolina Author Carrie Sybert Celebrates Three Published Books - 183
  • Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton - 128
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 123
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform - 120
  • 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST) - 116
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs - 115
  • Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options - 113
  • UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology - 111

Similar on ncarol.com

  • TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute